Active ingredient
Secukinumab
4 finished FDA listings contain Secukinumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- SECUKINUMAB
- Dosage forms
- Injection, Injection, Solution, Concentrate
- Routes
- Intravenous, Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 150 mg/ml · 25 mg/ml · 300 mg/2ml · 75 mg/.5ml
- Brand names in FDA listings
- Cosentyx
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1599788
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 125504 | NOVARTIS PHARMS CORP | 2015-01-21 | 3 |
| BLA 761349 | NOVARTIS PHARMS CORP | 2023-10-06 | 1 |
Official labeling on DailyMed
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.